Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: Response to a tailored decision aid

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 681-688

  Fagerlin, Angela ^a,b,c   Dillard, Amanda J ^a,c   Smith, Dylan M ^a,b,c   Zikmund Fisher, Brian J ^a,b,c   Pitsch, Rosemarie ^c   McClure, Jennifer B ^d   Greene, Sarah ^d   Alford, Sharon Hensley ^e   Nair, Vijayan ^b   Hayes, Daniel F ^b   Wiese, Cheryl ^d   Ubel, Peter A ^f,g  

^a Ann Arbor VA HSRandD Center for Practice Management and Outcomes Research   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Center for Behavioral and Decision Sciences in Medicine   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

^f DUKE UNIVERSITY   (United States)

^g DUKE UNIVERSITY   (United States)

Author keywords

Breast cancer prevention; Decision aids; Patient education; Raloxifene; Tamoxifen

Indexed keywords

RALOXIFENE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; FEMALE; HEALTH BEHAVIOR; HUMAN; PATIENT DECISION MAKING; PERCEPTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 79958271158     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1450-1     Document Type: Article

References (20)

1. ER Port LL Montgomery AS Heerdt PI Borgen 2001 Patient reluctance toward tamoxifen use for breast cancer primary prevention Ann Surg Oncol 8 7 580 585 11508619 10.1007/s10434-001-0580-9 1:STN:280:DC%2BD3MvmtlKgtg%3D%3D (Pubitemid 32735038)
2. D Stacey A O'Connor C De Grasse S Verma 2003 Development and evaluation of a breast cancer prevention decision aid for higher risk women Health Expect 6 1 3 18 12603624 10.1046/j.1369-6513.2003.00195.x (Pubitemid 36460039)
3. S Bober L Hoke R Duda M Regan N Tung 2004 Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors J Clin Oncol 22 24 4951 4957 15598980 10.1200/JCO.2004.05.192 (Pubitemid 46638620)
4. EA Waters KA Cronin BI Graubard PK Han AN Freedman 2010 Prevalence of tamoxifen use for breast cancer chemoprevention among U. S. women Cancer Epidemiol Biomarkers Prev 19 443 20142242 10.1158/1055-9965.EPI-09-0930 1:CAS:528:DC%2BC3cXhs1eis7s%3D
5. J Melnikow D Paterniti R Azari C Kuenneth S Birch M Kuppermann J Nuovo J Keyzer S Henderson 2005 Preferences of women evaluating risks of tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction Cancer 103 10 1996 2005 15825209 10.1002/cncr.20981 1:CAS:528: DC%2BD2MXkslyltLk%3D (Pubitemid 40605105)
6. D Stacey AM O'Connor C De Grasse S Verma 2003 Development and evaluation of a breast cancer prevention decision aid for higher-risk women Health Expect 6 3 18 12603624 10.1046/j.1369-6513.2003.00195.x (Pubitemid 36460039)
7. A Fagerlin B Zikmund-Fisher D Smith V Nair H Derry J McClure S Greene A Stark S Alford P Lantz, et al. 2010 Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid Breast Cancer Res Treat 119 613 620 19908143 10.1007/s10549-009-0618-4
8. T Salant PS Ganschow OI Olopade DS Lauderdale 2006 "Why take it if you don't have anything?" Breast cancer risk perceptions and prevention choices at a public hospital J Gen Intern Med 21 779 785 16808782 10.1111/j.1525-1497.2006.00461.x (Pubitemid 43973566)
9. KA Metcalfe C Snyder J Seidel D Hanna HT Lynch S Narod 2005 The use of preventative measures among healthy women who carry BRCA1 or BRCA2 mutation Familial Cancer 4 97 103 15951959 10.1007/s10689-005-4215-3 (Pubitemid 40897809)
10. V Vogel J Constantino D Wickerman, et al. 2006 Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes; the NSABP study of tamoxifen and raloxifene (STAR) P-2 Trial JAMA 295 23 2727 2741 16754727 10.1001/jama.295.23.joc60074 1:CAS:528: DC%2BD28XmtFOltLc%3D
11. R Donovan G Jalleh S Jones 2003 The word 'cancer': reframing the context to reduce anxiety arousal Aust N Z J Public Health 27 3 291 293 14705284 10.1111/j.1467-842X.2003.tb00397.x (Pubitemid 36705744)
12. DA Redelmeier E Shafir 1995 Medical decision making in situations that offer multiple alternatives J Am Med Assoc 273 4 302 305 10.1001/jama.273.4.302 1:STN:280:DyaK2M7hsFanuw%3D%3D
13. MH Gail LA Brinton DP Byar DK Corle SB Green C Schairer JJ Mulvihill 1989 Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 24 1879 1886 2593165 10.1093/jnci/81.24.1879 1:STN:280:DyaK3c%2FnvF2kuw%3D%3D (Pubitemid 20026073)
14. B Fisher JP Costantino DL Wickerham CK Redmond M Kavanah WM Cronin V Vogel A Robidoux N Dimitrov J Atkins, et al. 1998 Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study J Natl Cancer Inst 90 18 1371 1388 9747868 10.1093/jnci/90.18.1371 1:CAS:528:DyaK1cXmtlelurs%3D (Pubitemid 28439961)
15. AM O'Connor 1995 Validation of a decisional conflict scale Med Decis Mak 15 1 25 30 10.1177/0272989X9501500105
16. A Fagerlin BJ Zikmund-Fisher PA Ubel A Jankovic HA Derry DM Smith 2007 Measuring numeracy without a math test: development of the subjective numeracy scale Med Decis Mak 27 5 672 680 10.1177/0272989X07304449 (Pubitemid 47547594)
17. BJ Zikmund-Fisher DM Smith PA Ubel A Fagerlin 2007 Validation of the subjective numeracy scale (SNS): effects of low numeracy on comprehension of risk communications and utility elicitations Med Decis Mak 27 5 663 671 10.1177/0272989X07303824 (Pubitemid 47547593)
18. JT Cacioppo RE Petty 1982 The need for cognition J Pers Soc Psychol 42 116 131 10.1037/0022-3514.42.1.116
19. SL Neuberg JT Newsome 1993 Personal need for structure: individual differences in the desire for simple structure J Pers Soc Psychol 65 1 113 131 10.1037/0022-3514.65.1.113
20. B Meiser P Butow M Friedlander V Schnieden M Gattas J Kirk G Suthers E Haan K Tucker 2000 Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer J Clin Oncol 18 11 2250 2257 10829045 1:STN:280:DC%2BD3c3ptFaisw%3D%3D (Pubitemid 30350217)